Pfizer has won a $10 billion deal to acquire obesity drug developer Metsera, securing foothold in lucrative weight-loss treatment market. Rep. Jeff Van Drew, R-N.J., says safety is the number one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback